| 摘要 |
PROBLEM TO BE SOLVED: To provide anti-human CD26 antibody which enables analysis of CD26 expression in cancer tissues and immune tissues to select patients for a therapy or to follow-up effectiveness of the treatment, and can be used for immunostaining.SOLUTION: The invention relates to anti-human CD26 monoclonal antibodies or antigen-binding fragments thereof, which bind to an epitope that is recognized by a monoclonal antibody produced by a hybridoma deposited under the Accession Number NITE P-01642, a hybridoma deposited under the Accession Number NITE P-01643, or a hybridoma deposited under the Accession Number NITE P-01644. |
